Sickle cell disease is a severe, inherited blood disorder that primarily affects people of African, Mediterranean, Middle ...

Doctor Jeffrey Cummings is world-renowned in the field of Alzheimer's research and he leads UNLV's Center for Transformative ...

An estimated 7 out of every 100 veterans will be diagnosed with PTSD, according to the U.S. Department of Veter ...

The vast majority of people who have a substance use disorder (SUD) never seek treatment. At most, 10% of adults with a drug ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

U.S. Senator Kirsten Gillibrand is demanding answers on the closure of the 20-bed acute inpatient unit for veterans with substance use disorders at Castle Point VA Medical ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Integrative therapies take a holistic view of recovery, understanding that effective treatment must address the full spectrum of an individual’s life. This approach incorporates traditional medical ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for treating diabetes, work by stimulating insulin secretion and suppressing glucagon release, thereby helping regulate blood ...

It is estimated that about 60,000 people in the U.S. are currently living with FTD. Up to 40% of FTD cases have a genetic component and the patient receiving troculeucel is known to carry the C9orf72 ...